The Structural Genomics Consortium (SGC) and its clinical, industry and disease-foundation partners are launching open-source preclinical translational medicine studies.
Journal article
Nat rev drug discov
03/2015
14
149 - 150
Cell Line, Drug Evaluation, Preclinical, Humans, Patients, Primary Cell Culture, Public-Private Sector Partnerships, Translational Medical Research